c&o pharmaceutical technology (holdings) limited was founded as a comprehensivecompany integrating r&d, production and sales in 1997. we joined the big familyof shionogi & co., ltd. in 2011. thecompany has been playing an important role among the activities of chinesemarket during the process of globalization of the head office. a joint ventureof ping an-shionogi co., ltd. was established by shionogi (hong kong) co., ltd.and ping an life insurance company of china, ltd. in shanghai in november, 2020.c&o pharmaceutical technology (holdings) limited was merged into ping an-shionogi co., ltd. becoming an important part—thegeneric drug business segment of its business in february, 2021.
the company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
the company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
the company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
the company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
the company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.
the company has a high sense of corporate responsibility and always takes “saving patients” as its mission, expecting to bring benefits to more patients.